Literature DB >> 17699034

Epidemiology of mastitis in pasture-grazed peripartum dairy heifers and its effects on productivity.

C W R Compton1, C Heuer, K Parker, S McDougall.   

Abstract

An observational field study was conducted on 708 heifers in 30 spring-calving dairy herds in the Waikato region of New Zealand. The aim of the study was to describe patterns and effects of intramammary infection (IMI) and clinical mastitis (CM) in the peripartum period. Mammary secretion samples for bacteriological testing were taken from all quarters approximately 3 wk before the planned start of the calving period and within 5 d following calving, in addition to quarters diagnosed with CM within 14 d of calving. Precalving IMI was diagnosed in 18.5% of quarters, and of these, coagulase-negative staphylococci were the predominant isolate (13.5% of quarters). Streptococcus uberis prevalence increased 4-fold to 10.0% of quarters on the day of calving compared with the precalving period. Prevalence of all pathogens decreased rapidly following calving. Clinical mastitis cases were predominantly associated with Strep. uberis (64%). The daily hazard of diagnosis was higher in heifers than in cows (0.06 vs. 0.02/d on d 1 postcalving, respectively), but was not different by d 5 (0.005 vs. 0.002, respectively) of lactation. Intramammary infection with a major pathogen was associated with an increased risk of removal from the herd (15 vs. 10% for infected and noninfected heifers, respectively) and somatic cell count >200,000 cells/mL at subsequent herd tests (15 vs. 8%), but neither CM nor IMI were associated with reduced milk yield or milk solids production. Results suggest that bacterial species involved and the pattern of IMI prevalence in pasture-grazed peripartum heifers differ from those in other production systems. Further, mastitis control programs need to target major environmental pathogens causing precalving IMI, because new infections are likely before the onset of lactation, whereas existing detection and control measures are generally implemented after calving. Novel control programs that reduce new infections due to Strep. uberis immediately before calving are required to reduce the incidence of CM in pasture-grazed dairy heifers.

Entities:  

Mesh:

Year:  2007        PMID: 17699034     DOI: 10.3168/jds.2006-880

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  6 in total

1.  Effect of mastitis during the first lactation on production and reproduction performance of Holstein cows.

Authors:  Alireza Heravi Moussavi; Mohsen Danesh Mesgaran; Robert O Gilbert
Journal:  Trop Anim Health Prod       Date:  2012-02-23       Impact factor: 1.559

2.  The prevalence of heifer mastitis and its associated risk factors in Huanggang, Central China.

Authors:  Feng Li Yang; Chen Shen; Bao Xiang He; Yu Ying Yang; Da Chun Gong; Xiao Shan Li
Journal:  Trop Anim Health Prod       Date:  2014-10-08       Impact factor: 1.559

3.  Interleukin-1beta infusion in bovine mammary glands prior to challenge with Streptococcus uberis reduces bacterial growth but causes sterile mastitis.

Authors:  D Neil Wedlock; Michel Denis; Jane Lacy-Hulbert; Bryce M Buddle
Journal:  Vet Res Commun       Date:  2008-04-19       Impact factor: 2.459

4.  Feeding mastitis milk to organic dairy calves: effect on health and performance during suckling and on udder health at first calving.

Authors:  Katharina Abb-Schwedler; Ariane Maeschli; Renate Boss; Hans U Graber; Adrian Steiner; Peter Klocke
Journal:  BMC Vet Res       Date:  2014-11-25       Impact factor: 2.741

Review 5.  Culling and mortality of dairy cows: why it happens and how it can be mitigated.

Authors:  Diniso Simamkele Yanga; Ishmael Festus Jaja
Journal:  F1000Res       Date:  2021-10-06

6.  Evidence for niche adaptation in the genome of the bovine pathogen Streptococcus uberis.

Authors:  Philip N Ward; Matthew T G Holden; James A Leigh; Nicola Lennard; Alexandra Bignell; Andy Barron; Louise Clark; Michael A Quail; John Woodward; Bart G Barrell; Sharon A Egan; Terence R Field; Duncan Maskell; Michael Kehoe; Christopher G Dowson; Neil Chanter; Adrian M Whatmore; Stephen D Bentley; Julian Parkhill
Journal:  BMC Genomics       Date:  2009-01-28       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.